$4.54
-0.16-3.30%
Pre-Market: Nov 18, 3:10 AM EDT
Comments
Loading...
Valneva (NASDAQ:VALN) Stock Quotes, Forecast and News Summary
Valneva Stock (NASDAQ: VALN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Valneva (VALN) stock?
You can purchase shares of Valneva (NASDAQ:VALN) through any online brokerage.
Who are Valneva (VALN) competitors?
Other companies in Valneva’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Sage Therapeutics (NASDAQ:SAGE) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for Valneva (VALN) stock?
Valneva has a consensus price target of $18.50.
What is the current price for Valneva (VALN)?
The stock price for Valneva (NASDAQ: VALN) is $4.54 last updated November 18, 2024 at 3:10 AM EST.
Does Valneva (VALN) pay a dividend?
There are no upcoming dividends for Valneva.
When is Valneva (NASDAQ:VALN) reporting earnings?
Valneva’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Valneva (VALN) going to split?
There is no upcoming split for Valneva.
What sector and industry does Valneva (VALN) operate in?
Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.